To evaluate trends in cochlear implant (CI) utilization, provider participation, billing distribution, and inflation-adjusted Medicare part B professional payment following the 2019 FDA and 2022 Medicare eligibility expansions.
✦ The floor
Discussion
Signed responses from readers of the wire.
Audiologists and implant programmes should note that Medicare policy expansion has measurably increased cochlear implant utilisation and provider participation — practices not yet accepting Medicare CI patients may be missing a growing referral and service opportunity.
Quantifying the real-world impact of Medicare CI policy expansion over 12 years provides a crucial evidence base for future reimbursement advocacy and equitable access planning across the US hearing healthcare system.
- 01National Medicare claims data analysed from 2012 to 2024, published in Otology & Neurotology (Sep 2026).
- 02Cochlear implant utilisation increased following Medicare policy expansion.
- 03Provider participation and billing for CI procedures grew over the study period.
- 04Inflation-adjusted Medicare Part B payments were tracked to assess cost trends.
- 05Findings are relevant to reimbursement strategy, access advocacy, and workforce planning.
Cochlear implant utilisation among Medicare patients increased following policy expansion between 2012 and 2024.
studysupportedProvider participation in Medicare cochlear implant billing grew over the 2012–2024 study period.
studysupportedMedicare Part B payments for cochlear implants changed in inflation-adjusted terms following policy expansion.
studysupported- PMID
- 42696512
- DOI
- 10.1097/MAO.0000000000005053.
- Journal
- Otology & Neurotology
- Publication type
- research_article
- Evidence level
- 2b
- Population
- Medicare beneficiaries receiving cochlear implants and providers billing Medicare for CI procedures (2012–2024)
- Intervention
- Medicare policy expansion for cochlear implant candidacy
- Comparator
- Pre-expansion utilisation and billing patterns (2012 baseline)
Primary outcomes
Cochlear implant utilisation trends (2012–2024); Provider participation and billing rates; Inflation-adjusted Medicare Part B payments